Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Molecular Diagnostics : JMD|September 3, 2011
Paraffin embedding contributes to RNA aggregation, reduced RNA yield, and low RNA qualityDavid L Evers, Junkun He, Yeon Ho Kim, et al.
Antiviral Research|January 18, 2005
Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778David L Evers, Xin Wang, Shu-Mei Huong, et al.
The Journal of Molecular Diagnostics : JMD|April 19, 2011
The effect of formaldehyde fixation on RNA: optimization of formaldehyde adduct removalDavid L Evers, Carol B Fowler, Brady R Cunningham, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activityDavid L Evers, Julie M Breitenbach, Katherine Z Borysko, et al.
Antiviral Research|September 29, 2005
Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of actionDavid L Evers, Chih-Fang Chao, Xin Wang, et al.
Antiviral Research|September 27, 2002
Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirusDavid L Evers, Gloria Komazin, Dongjin Shin, et al.
Current Research in Toxicology|August 4, 2021
Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartanThu-Lan T Luong, Michael J McAnulty, David L Evers, et al.
Journal of Virology|March 31, 2006
Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradationZhigang Zhang, David L Evers, Joseph F McCarville, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2004
Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanismsDavid L Evers, Gloria Komazin, Roger G Ptak, et al.
Pageof 3